Safety Observation on hESC Derived MSC Like Cell for the Meniscus Injury
NCT ID: NCT03839238
Last Updated: 2019-02-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE1
18 participants
INTERVENTIONAL
2019-01-04
2020-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mesenchymal Stem Cells in Knee Cartilage Injuries
NCT02118519
Intra-articular Injection of MSCs in Treatment of Knee OA
NCT03028428
Treatment of Cartilage Defects With Peripheral Blood Stem Cells
NCT04953572
Clinical Efficacy of Exosome in Degenerative Meniscal Injury
NCT05261360
Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Knee Osteoarthritis
NCT05160831
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Meniscus Injured patients
hESC Derived MSC Like Cell
hESC derived MSC like cell
Different dosage of hESC derived MSC like cell for the meniscus injured patients
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
hESC derived MSC like cell
Different dosage of hESC derived MSC like cell for the meniscus injured patients
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The patients who still have the pain of knee joint and/or limitation of the function after accepted 3 months of nonoperative treatment
Exclusion Criteria
* The patients who have meniscus injury of knee joint need the surgical repair
* The patients who have the severe coagulation disorders, cardiopulmonary failure and so on
* The women who are pregnant or nursing
* There are electronic implants such as pacemakers in the body
* The patients who are infected the HIV, the virus of hepatitis or syphilis
* The patients who are alcoholism or drug user
* The patients who have vestibular and balance disorders
* The patients with severe cognitive impairment who cannot follow instructions to complete the treatment
* The patients who don't sign the informed consent
* The patients who have tumor
* Immunodeficiency patients
* The patients who have congenital or acquired knee malformation
* Patients or researchers who are participating in other clinical trials believe that other reasons are not appropriate for clinical trials
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chinese Academy of Sciences
OTHER_GOV
Tongji Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hong Chen, Doctor
Role: STUDY_DIRECTOR
Wuhan TongJi Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tongji Hospital, Tongji Medical College of Science and Technology
Wuhan, Hubei, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Wuhan Tongji Hospital
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.